Herpes Simplex Virus Vector-Mediated Dystrophin Gene Transfer and Expression in MDX Mouse Skeletal Muscle

Journal of Gene Medicine

Volumn 1, Issue 4, 1999, Pages 280-289

  Akkaraju, Giridhar R ^b   Huard, Johnny ^a   Hoffman, Eric P ^b   Goins, William F ^b   Pruchnic, Ryan ^a   Watkins, Simon C ^b   Cohen, Justus B ^b   Glorioso, Joseph C ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Dystrophin; Gene therapy; HSV vector; Muscle

Indexed keywords

HERPES; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

DYSTROPHIN;

ANIMAL; ANIMAL MUSCULAR DYSTROPHY; ARTICLE; CELL LINE; DEFECTIVE VIRUS; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HERPES SIMPLEX VIRUS 1; IN VITRO STUDY; METABOLISM; MOUSE; SKELETAL MUSCLE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CELL LINE; DEFECTIVE VIRUSES; DYSTROPHIN; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL;

EID: 0033154485     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-2254(199907/08)1:4<280::AID-JGM45>3.0.CO;2-L     Document Type: Article

References (65)

1. Hoffman E, Brown R, Kunkel L. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919-928.
2. Koenig M, Monaco AP, Kunkel LM. The complete sequence of Dystrophin protein predicts a rod-shaped cytoskeletal protein. Cell 1988; 53: 219-228.
3. Monaco AP, Neve RL, Colletti-Feener C, Bertelson CJ, Kurnit DM, Kunkel LM. Isolation of candidate cDNAs for portions of the Duchenne Muscular Dystrophy gene. Nature 1986; 323: 646-650.
4. Ahn AH, Kunkel LM. The structural and functional diversity of Dystrophin. Nat Genet 1995; 3: 283-291.
5. Hoffman EP, Kunkel LM. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron 1989; 2: 1019-1029.
6. Hoffman EP, Fischbeck KH, Brown RH, Johnson M, Medori R, Loike JD, Harris JB, Waterston R, Brooke M, Specht L, et al. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Beeker's muscular dystrophy. N Engl J Med 1988; 318: 1363-1368.
7. Clemens PR, Krause TL, Chan S, Korb KE, Graham FL, Caskey CT. Recombinant truncated dystrophin minigenes: Construction, expression, and adenoviral delivery. Hum Gene Ther 1995; 6: 1477-1485.
8. Deconinck N, Ragot T, Marechal G, Perricaudet M, Gillis JM. Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Pro. Natl Acad Sci U S A 1996; 93: 3570-3574.
9. Phelps S, Hauser M, Cole N, Rafael J, Hinkle R, Faulkner J, Chamberlain J. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Hum Mol Genet 1995; 4: 1251-1258.
10. Dunckley MG, Love DR, Davies KE, Walsh FS, Morris GE, Dickson G. Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro. FEES Lett 1992; 296: 128-134.
11. Fassati A, Wells DJ, Sgro Serpente PA, Walsh FS, Brown SC, Strong PN, Dickson G. Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells. J Clin Invest 1997; 100: 620-628.
12. Howell JM, Lochmuller H, O'Hara A, Fletcher S, Kakulas BA, Massie B, Nalbantoglu J, Karpati G. High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle. Hum Gene Ther 1998; 9: 629-634.
13. Moisset PA, Skuk D, Asselin I, Goulet M, Roy B, Karpati G, Tremblay JP. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the Dystrophin minigene. Biochem Biophys Res Commun 1998; 247: 94-99.
14. Ragot T, Vincent N, Chafey P, Gilgenkrantz H, Couton D, Cartaud J, Briand P, Kaplan J-C, Perricaudet M, Karin A. Efficient adneovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 1993; 321: 647-650.
15. Vincent N, Ragot T, Gilgenkrantz H, Couton D, Chafey P, Gregoire A, Briand P, Kaplan J-C, Kahn A, Perricaudet M. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat Genet 1993; 5: 130-134.
16. Floyd SS, Clemens PR, Ontell MR, Kochanek S, Day CS, Yang J, Hauschka SD, Balkir L, Morgan J, Moreland MS, Feero GW, Epperly M, Huard J. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscle. Gene Ther 1998; 5: 19-30.
17. Haecker SE, Stedman HH, Balice-Gordon RJ, Smith DB, Greelish JP, Mitchell MA, Wells A, Sweeney HL, Wilson JM. In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum Gene Ther 1996; 7: 1907-1914.
18. Kochanek S, Clemens PR, Mitani K, Chen H-H, Chan S, Caskey CT. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length Dystrophin and b-galactosidase. Proc Nat Acad Sci U S A 1996; 93: 5731-5736.
19. Kumar-Singh R, Chamberlain J. Encapsidated adenovirus minichromosomes allow delivery and expression of a 14kb dystropnin cDNA to muscle cells. Hum Mol Genet 1996; 5: 913-921.
20. Acsadi G, Jani A, Massie B, Simoneau M, Holland P, Blaschuk K, Karpati G. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Mol Genet 1994; 3: 579-584.
21. Feero WG, Rosenblatt JD, Huard J, Watkins SC, Epperly M, Clemens PR, Kochanek S, Glorioso JC, Patridge TA, Hoffman EP. Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors. Hum Gene Ther 1997; 8: 371-380.
22. Wickham TJ, Segal DM, Roelvink PW, Carrion ME, Lizonova A, Lee GM, Kovesdi I. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J Virol 1996; 70: 6831-6838.
23. Roizman B, Sears A. Herpes simplex viruses and their replication. Fields Virol 1996; 2: 2231-2295.
24. Krisky DM, Marconi PC, Oligino T, Rouse RJD, Fink DJ, Glorioso JC. Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther 1997; 4: 1120-1125.
25. Krisky DM, Marconi PC, Oligino TJ, Rouse RJD, Fink DJ, Cohen JB, Watkins SC, Glorioso JC. Development of herpes simplex virus replication defective multigene vectors for combination gene therapy applications. Gene Ther 1998; 5: 1517-1530.
26. Rasty S, Poliani P, Fink D, Glorioso J. Deletion of the S component inverted repeat sequence c′ and the nonessential genes Us1 through Us5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system. J Neurovirol 1997; 3: 247-264.
27. Honess R, Roizman B. Regulation of herpes simplex virus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol 1974; 14: 8-19.
28. DeLuca NA, Schaffer PA. Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4. Mol Cell Biol 1985; 5: 1997-2008.
29. Dixon RAF, Schaffer PA. Fine-structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP175. J Virol 1980; 36: 189-203.
30. McCarthy AM, McMahan L, Schaffer PA. Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J Virol 1989; 63: 18-27.
31. Sacks W, Greene C, Aschman D, Schaffer P. Herpes simplex virus type 1 ICP27 is essential regulatory protein. J Virol 1985; 55: 796-805.
32. Holland LE, Anderson KP, Shipman C, Wagner EK. Viral DNA synthesis is required for efficient expression of specific herpes simplex virus type 1 mRNA. Virology 1980; 101: 10-24.
33. Mavromara-Nazos P, Roizman B. Activation of herpes simplex virus 1 g2 genes by viral DNA replication. Virology 1987; 161: 593-598.
34. Brown CR, Nakamura MS, Mosca JD, Hayward GS, Straus ST, Perera LP. Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNA. J Virol 1995; 69: 7187-7195.
35. McGregor F, Phelan A, Dunlop J, Clements J. Regulation of herpes simplex virus poly(A) site usage and the action of immediate-early protein IE63 in the early-late switch. J Virol 1996; 70: 1931-1940.
36. Sandri-Goldin R, Hibbard M. The herpes simplex virus type 1 regulatory protein ICP27 coimmunoprecipitates with anti-sm antiserum, and the C terminus appears to be required for this interaction. J Virol 1996; 70: 108-118.
37. Hill A, Ploegh H. Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigen. Proc Natl Acad Sci USA 1995; 92: 341-343.
38. York I, Roop C, Andrews D, Riddell S, Graham F, Johnson D. A cytosolic herpes simplex virus protein inhibits antigen presentation to CDS+ T lymphocytes. Cell 1994; 77: 525-535.
39. DeLuca NA, McCarthy AM, Schaffer PA. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 1985; 56: 558-570.
40. Johnson PA, Miyanohara A, Levine F, Cahill T, Friedmann T. Cytotoxicity of a replication-defective mutant herpes simplex virus type 1. J Virol 1992; 66: 2952-2965.
41. Johnson P, Wang M, Friedmann T. Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the viron host shutoff function. J Virol 1994; 68: 6347-6362.
42. Krisky DM, Wolfe D, Goins WF, Marconi PC, Ramakrishnan R, Mata M, Rouse RJD, Fink DJ, Glorioso JC. Deletion of multiple immediate early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther 1998; 5: 1593-1603.
43. Marconi P, Krisky D, Oligino T, Poliani PL, Ramakrishnan R, Goins WF, Fink DJ, Glorioso JC. Replication-defective HSV vectors for gene transfer in vivo. Proc Natl Acad Sci U S A 1996; 93: 11319-11320.
44. Samaniego L, Webb A, DeLuca N. Functional interaction between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4. J Virol 1995; 69: 5705-5715.
45. Samaniego L, Wu N, DeLuca NA. The herpes simplex virus immediate-early protein ICPO affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J Virol 1997; 71: 4614-4625.
46. Wu N, Watkins SC, Schaffer PA, DeLuca NA. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J Virol 1996; 70: 6358-6368.
47. Samaniego LA, Neiderhiser L, DeLuca NA. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J Virol 1998; 72: 3307-3320.
48. Huard J, Goins WF, Glorioso JC. Herpes simplex virus type 1 vector mediated gene transfer to muscle. Gene Ther 1995; 2: 385-393.
49. Lee CC, Pearlman JA, Chamerlain JS, Caskey CT. Expression of recombinant Dystrophin and its localization to the cell membrane. Nature 1991; 349: 334-336.
50. England SB, Nicholson LVB, Johnson MA, Forrest SM, Love DR, Zubrzycka-Gaarn EE, Bulman DE, Harris JB, Davies KE. Very mild muscular dystrophy associated with the deletion of 46% of Dystrophin. Nature 1990; 343: 180-182.
51. Oligino T, Poliani PL, Marconi P, Bender MA, Schmidt MC, Fink DJ, Glorioso JC. In vivo transgene activation from an HSV-based gene vector by GAL4:VP16. Gene Ther 1996; 3: 892-899.
52. Goins WF, Marconi P, Krisky D, Ramakrishnan R, Fink DJ, Glorioso JC. Construction of replication defective herpes simplex virus vectors. Curr Prot Hum Genet 1996; 12: 2.1-2.29.
53. Krisky D, Marconi P, Goins WF, Glorioso JC. Development of replication-defective herpes simplex virus vectors. Methods Mol Med Gene Ther Prot 1996; P Robbins (ed.), Humana Press, pp. 79-102.
54. Byers TJ, Kunkel LM, Watkins SC. The subcellular distribution of Dystrophin in mouse skeletal, cardiac and smooth muscle. J Cell Biol 1991; 115: 411-421.
55. Morgan JE, Beauchamp JR, Pagel CN, Peckham M, Ataliotis P, Jat PS, Nobel MD, Farmer K, Partridge TA. Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cellline. Dev Biol 1994; 162: 486-498.
56. Hoffman EP, Morgan JE, Watkins SC, Partridge TA. Somatic reversion/suppresion of the mouse mdx phenotype in vivo. J Neurol Sci 1990; 99: 9-25.
57. Hoffman EP, Beggs AH, Koenig M, Kunkel LM, Angelini C. Cross-reactive protein in Duchenne muscle. Lancet 1989; ii: 1211-1212.
58. Koenig M, Kunkel LM. Detailed analysis of the repeat domain of Dystrophin reveals four potential hinge regions that may confer flexibility. J Biol Chem 1990; 265: 4560-4566.
59. Clemens PR, Lee CC, Caskey CT. Gene transfer of a murine Dystrophin minigene construct. Gene Transfer and Therapy in the Nervous System 1992; FH Gage and Y Christen (eds.), Springer-Verlag, Berlin, pp. 158-166.
60. Huard J, Krisky D, Oligino T, Marconi P, Day CS, Watkins SC, Glorioso JC. Gene transfer to muscle using herpes simplex virus-based vectors. Neuromuscul Disord 1997; 7: 299-313.
61. Huard J, Goins WF, Akkaraju GR, Krisky D, Oligino T, Marconi P, Day CS, Glorioso JC. Gene transfer to muscle and spinal cord using herpes simplex virus-based vectors. Stem Cell Biol Gene Ther 1998; PJ Quesenberry, GS Stein, B Forget and S Weissman (eds.), John Wiley & Sons, Inc., pp. 179-200.
62. Xiao X, Li J, Samulski RJ. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 1996; 70: 8098-8108.
63. Huard J, Akkaraju G, Watkins SC, Pike-Cavalcoli M, Glorioso JC. LacZ gene transfer to skeletal mucsle using a replication-defective herpes simplex virus type 1 mutant vector. Hum Gene Ther 1997; 8: 439-452.
64. Huard J, Feero W, Watkins S, Hoffman E, Rosenblatt D, Glorioso J. The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers. J Virol 1996; 70: 8117-8123.
65. van Deutekom JC, Floyd SS, Booth DK, Oligino T, Krisky D, Marconi P, Glorioso JC, Huard J. Implications of maturation for viral gene delivery to skeletal muscle. Neuromuscul Disord 1998; 8: 135-148.